Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000221

Chief Executive Officer sold 203,814 shares at an average $60.32 ($12,294,703)

  • Chief Executive Officer acquired 203,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Monia Brett P · Chief Executive Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-03 Exercise or conversion : show line 1 in the form +102,900 $53.77 $5,532,933 282,909 D
2025-09-03 Sale : show line 2 in the form −16,615 $59.12 $982,262 266,294 D
2025-09-03 Exercise or conversion : show line 3 in the form +42,030 $37.58 $1,579,487 308,324 D
2025-09-03 Sale : show line 4 in the form −127,500 $60.13 $7,667,047 180,824 D
2025-09-03 Exercise or conversion : show line 5 in the form +31,316 $32.60 $1,020,902 212,140 D
2025-09-03 Exercise or conversion : show line 6 in the form +27,568 $32.60 $898,717 239,708 D
2025-09-03 Sale : show line 7 in the form −59,699 $61.06 $3,645,394 180,009 D
Open-market sales · 203,814 sh · avg $60.32 · $12,294,703

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-09-03 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) −31,316 67,741 D
2025-09-03 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −27,568 40,173 D
2025-09-03 Exercise or conversion : show line 10 in the form Non-Qualified Stock Option (right to buy) −42,030 76,643 D
2025-09-03 Exercise or conversion : show line 11 in the form Non-Qualified Stock Option (right to buy) −102,900 0 D
Loading xslF345X05/edgardoc.xml…